Research Study

A Multi-Centre, Randomized Controlled Study on the Zimmer TM Glenoid Component Compared to Cemented Glenoid Component
Principal Investigator 
Patrick Chin


Body Locations and Systems 
Diagnosis and Therapy 
Surgery and Rehabilitation 
Closed for Recruitment
Study Start/End 
Aug 1, 2012 to Aug 1, 2024
Richmond Health Services, UBC Hospital, Vancouver General Hospital
Brendan Lim, Research Coordinator
Email Address
Purpose of Study 

The objective of this randomized controlled study is to obtain outcomes data on the Zimmer TM glenoid component by analysis of standard scoring systems and radiographs in comparison to the cemented glenoid component. In addition, the investigators plan to provide cost analysis based on the economic data collected to justify the cost difference between both implants.

Patients with acceptable glenoid bone stock will be randomized into two groups to be treated with either a TM Glenoid or cemented glenoid component with minimum 2 years follow-up; maximum 10 years follow-up.


Visit for more information.


Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.